Trial Profile
Safety of oral dofetilide for rhythm control in patients with atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2015
Price :
$35
*
At a glance
- Drugs Dofetilide (Primary)
- Indications Atrial fibrillation
- Focus Adverse reactions
- 18 Nov 2015 New trial record